skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: LIGHT, a member of the TNF superfamily, activates Stat3 mediated by NIK pathway

Journal Article · · Biochemical and Biophysical Research Communications
 [1];  [1];  [1];  [1];  [2];  [1]
  1. Departments of Medicine, Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263 (United States)
  2. Department of Molecular Oncology, MD Anderson Cancer Center, Houston, TX 77030 (United States)

Stat3, a member of the signal transducers and activators of transcription (STAT) family, is a key signal transduction protein activated by numerous cytokines, growth factors, and oncoproteins that controls cell proliferation, differentiation, development, survival, and inflammation. Constitutive activation of Stat3 has been found frequently in a wide variety of human tumors and induces cellular transformation and tumor formation. In this study, we demonstrated that LIGHT, a member of tumor necrosis factor superfamily, activates Stat3 in cancer cells. LIGHT induces dose-dependent activation of Stat3 by phosphorylation at both the tyrosine 705 and serine 727 residues. The activation of Stat3 by LIGHT appears to be mediated by NIK phosphorylation. Expression of a kinase-inactive NIK mutant abolished LIGHT induced Stat3 activation. Overexpression of an active NIK induces Stat3 activation by phosphorylation at the both tyrosine 705 and serine 727 residues. Activation of Stat3 by NIK requires NIK kinase activity as showed by kinase assays. In addition, LIGHT increases the expression of Stat3 target genes including cyclin D1, survivin, and Bcl-xL, and stimulates human LNCaP prostate cancer cell growth in vitro which can be blocked by expression of a dominant-negative Stat3 mutant. Taken together, these results indicate that in addition to activating NF-{kappa}B/p52, LIGHT also activates Stat3. Activation of Stat3 together with activating non-canonical NF-{kappa}B/p52 signaling by LIGHT may maximize its effects on cellular proliferation, survival, and inflammation.

OSTI ID:
20991459
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 359, Issue 2; Other Information: DOI: 10.1016/j.bbrc.2007.05.119; PII: S0006-291X(07)01093-5; Copyright (c) 2007 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English